Overview
A Study of Single Dose of ABT-333 in Healthy Male Adults
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
The objectives of this study is to assess the safety, tolerability, and pharmacokinetics of blind, escalating, single, oral doses of ABT-333 under nonfasting conditions in healthy male adult in Japan.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
AbbottCollaborator:
Abbott Japan Co.,Ltd
Criteria
Inclusion Criteria:- Subject has provided written consent.
- Subject is in general good health.
Exclusion Criteria:
- See above for main selection criteria.